Work

Supplementary Figure 12 from NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion

Year: 2024

Type: supplementary-materials

Abstract: Combination of FK866 and olaparib leads to sustained cell cycle arrest in G2.

DOI: 10.1158/1541-7786.27151087

Authors: Katelyn J. Noronha, Karlie N. Lucas, Sateja Paradkar, Joseph Edmonds, Sam Friedman, Matthew A. Murray, Samantha Liu, Dipti P. Sajed, Chana Sachs, Josh Spurrier, Mitch Raponi, Jiayu Liang, Hao Zeng, Ranjini K. Sundaram, Brian Shuch, Juan C. Vasquez, Ranjit S. Bindra

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4403076500

Cites:

Cited by:

Related to: 10